Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 828.852K |
Day Range | - - - |
52 Wk Range | 9.560 - 31.460 |
Market Cap | $779.143M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 29.76% |
Days to Cover | 27.42 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zentalis Pharma (NASDAQ: ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Centessa Pharmaceuticals (NASDAQ:CNTA).
The latest price target for Zentalis Pharma (NASDAQ: ZNTL) was reported by HC Wainwright & Co. on Wednesday, February 28, 2024. The analyst firm set a price target for 46.00 expecting ZNTL to rise to within 12 months (a possible 318.94% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $10.98 last updated April 25, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.